Agila Speclts Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AGILA SPECLTS, and what generic and branded alternatives to AGILA SPECLTS drugs are available?
AGILA SPECLTS has one approved drug.
Summary for Agila Speclts
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Agila Speclts
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Agila Speclts | CEFTRIAXONE | ceftriaxone sodium | INJECTABLE;INJECTION | 091068-001 | Jan 7, 2013 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
